Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Next-generation Sequencing03:00

Next-generation Sequencing

97.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
97.9K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

238
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
238

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding skin aging: Emerging roles of miRNAs, lncRNAs, and circRNAs in mechanisms, therapies, and future horizons.

Ageing research reviews·2026
Same author

Interpretable Deep Learning for Single-Molecule Nanopore Fingerprinting Using Physics-Guided Preprocessing.

ACS sensors·2026
Same author

MicroRNA spatial profiling for assessing drug efficacy in <i>BRCA1</i> -related triple-negative breast tumors.

bioRxiv : the preprint server for biology·2026
Same author

High-Concentration Antibody Formulation via Solvent-Based Dehydration.

Advanced materials (Deerfield Beach, Fla.)·2025
Same author

Surface-Mediated Self-Assembly of Kinetoplast DNA: Depletion-Driven Dimer Formation and Quasi-2D Dynamics.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Single-Molecule DNA Tweezers Enable Programmable Control of Enzyme Activity via Arbitrary Molecular Cues.

Angewandte Chemie (International ed. in English)·2025
Same journal

Hydrogen evolution and dynamics in hydrogel electrochemical cells for ischemia-reperfusion therapy.

Nature chemical engineering·2026
Same journal

Photoreforming of solid waste on 1 m<sup>2</sup> scale using single-source precursor-derived co-catalyst films.

Nature chemical engineering·2026
Same journal

A knowledge graph framework for digital twins of chemical processes.

Nature chemical engineering·2026
Same journal

Neural network-assisted personalized handwriting analysis for Parkinson's disease diagnostics.

Nature chemical engineering·2026
Same journal

Transient pH changes drive vacuole formation in enzyme-polymer condensates.

Nature chemical engineering·2026
Same journal

Water dissociation efficiencies control the viability of reverse-bias bipolar membranes for CO<sub>2</sub> electrolysis.

Nature chemical engineering·2025
See all related articles

Related Experiment Video

Updated: Jan 18, 2026

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

8.4K

Engineering Considerations for Developing Next-Generation Oligonucleotide Therapeutics.

Sasha B Ebrahimi1, Himanshu Bhattacharjee1, Sujatha Sonti2

  • 1Emerging Drug Delivery Platforms, GlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, PA, USA.

Nature Chemical Engineering
|June 2, 2025
PubMed
Summary
This summary is machine-generated.

Chemical engineering is crucial for advancing oligonucleotide therapeutics beyond the liver. This involves biomolecular and process engineering to improve drug stability, targeting, and delivery for wider disease treatment.

More Related Videos

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
05:33

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Published on: July 5, 2024

1.3K
Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism
11:37

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Published on: July 28, 2017

19.7K

Related Experiment Videos

Last Updated: Jan 18, 2026

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

8.4K
Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication
05:33

Author Spotlight: Characterizing Novel Enzymes from Extremophiles and Common Pathogens to Understand DNA Repair and Replication

Published on: July 5, 2024

1.3K
Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism
11:37

Protocol for the Solid-phase Synthesis of Oligomers of RNA Containing a 2'-O-thiophenylmethyl Modification and Characterization via Circular Dichroism

Published on: July 28, 2017

19.7K

Area of Science:

  • Biotechnology
  • Chemical Engineering
  • Genetics

Background:

  • Oligonucleotide therapeutics offer a novel approach to treating diseases by targeting genetic material.
  • Current applications are limited due to challenges in delivering these drugs to tissues outside the liver.

Purpose of the Study:

  • To highlight the essential role of chemical engineering in overcoming delivery challenges for oligonucleotide therapeutics.
  • To discuss the integration of biomolecular and process engineering for next-generation therapeutics.

Main Methods:

  • Collaborative perspective from academic and industry experts.
  • Analysis of biomolecular engineering strategies for enhanced stability, targeting, and pharmacokinetics.
  • Discussion of process engineering techniques for oligonucleotide development.

Main Results:

  • Chemical engineering is pivotal for expanding the clinical utility of oligonucleotide therapeutics.
  • Interplay between biomolecular and process engineering is key to "undruggable" disease treatment.
  • Improved engineering enhances developability and clinical translation.

Conclusions:

  • Advancements in chemical and biomolecular engineering are necessary to broaden the application of oligonucleotide therapeutics.
  • Integrated engineering approaches will enable treatment of a wider range of diseases.
  • This perspective emphasizes the bench-to-bedside translation facilitated by engineering innovations.